Ankur Luthra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ankur Luthra has a total of 160 co-authors. Here are the top co-authors by number of shared publications:
Rajeev Chauhan
Department of Anaesthesia and Intensive Care, Post Graduate Institute of Medical Education and Research, Chandigarh, India
13 shared publications- Rajeev Chauhan
Department of Anesthesia and Intensive Care, Post Graduate Institute of Medical Education and Research, Chandigarh, India
11 shared publications Nidhi Panda
Department of Anesthesia and Intensive Care
6 shared publicationsAshwini Reddy
Department of Anaesthesia and Intensive Care, Post Graduate Institute of Medical Education and Research, Chandigarh, India
5 shared publicationsHemant Bhagat
Department of Anesthesia and Intensive Care
5 shared publications- Shyam Charan Meena
Department of Anaesthesia and Intensive Care, Post Graduate Institute of Medical Education and Research, Chandigarh, India
5 shared publications
Latest Publications
- Open Access
- 18 June 2026
- Published by Springer Nature in BMC Anesthesiology
- Vol. 26 (1)
Comparison of the efficacy of Dexmedetomidine versus Ketamine as an adjunct to Ropivacaine for Scalp nerve block during Awake craniotomy surgery- A Randomised Controlled Trial
Scalp nerve block (SNB) is an established technique for effective analgesia during awake craniotomy, but its analgesic duration is limited when local anesthetics are used alone. Adjuvants such as dexmedetomidine and ketamine may enhance block efficacy, though direct comparative evidence remains limited. This prospective trial randomized forty-six adult patients undergoing elective awake craniotomy to receive SNB with 0.5% ropivacaine with dexmedetomidine 1 µg/kg (Group RD, n = 23) or ketamine 0.5 mg/kg (Group RK, n = 23). The primary outcome was the time to request the first rescue analgesia. Secondary outcomes included onset of sensory blockade, postoperative pain scores, rescue analgesic consumption, hemodynamic variables, respiratory depression, psychosis, and time to discharge from the postoperative ward. The time to first rescue analgesia was significantly longer in Group RK compared with Group RD (18.67 [17.08-19.00] vs. 14.67 [12.92-15.08] hours; P = 0.001). Group RK demonstrated significantly lower postoperative pain scores at 6,10, and 16 h postoperatively (P < 0.004) and reduced consumption of rescue analgesia (P < 0.001). The onset of sensory blockade was comparable with a higher incidence of respiratory depression in Group RD (P = 0.02). Group RK showed higher intraoperative heart rate and mean arterial pressure, though values remained within clinically acceptable limits. Ketamine (0.5 mg/kg) as an adjuvant to ropivacaine for SNB in awake craniotomy provides longer postoperative analgesia and reduced rescue analgesic requirements compared with dexmedetomidine, with a lower incidence of respiratory depression. Dexmedetomidine offers superior hemodynamic attenuation to noxious stimuli. Larger multicenter studies are warranted to establish optimal adjuvant selection. Clinical Trials Registry-India (CTRI): CTRI/2024/01/061259, https://ctri.nic.in/Clinicaltrials/pmaindet2.php?EncHid=OTY2NDQ=&Enc=&userName= Date of registration: 09/01/2024 Date of enrolment of first patient: 15/01/2024 Principal Investigator: Dr Ankur Luthra.
- 18 June 2026
- Published by Springer Nature in BMC Anesthesiology
- Vol. 26 (1)
Open AccessComparison of the efficacy of Dexmedetomidine versus Ketamine as an adjunct to Ropivacaine for Scalp nerve block during Awake craniotomy surgery- A Randomised Controlled Trial
Scalp nerve block (SNB) is an established technique for effective analgesia during awake craniotomy, but its analgesic duration is limited when local anesthetics are used alone. Adjuvants such as dexmedetomidine and ketamine may enhance block efficacy, though direct comparative evidence remains limited. This prospective trial randomized forty-six adult patients undergoing elective awake craniotomy to receive SNB with 0.5% ropivacaine with dexmedetomidine 1 µg/kg (Group RD, n = 23) or ketamine 0.5 mg/kg (Group RK, n = 23). The primary outcome was the time to request the first rescue analgesia. Secondary outcomes included onset of sensory blockade, postoperative pain scores, rescue analgesic consumption, hemodynamic variables, respiratory depression, psychosis, and time to discharge from the postoperative ward. The time to first rescue analgesia was significantly longer in Group RK compared with Group RD (18.67 [17.08-19.00] vs. 14.67 [12.92-15.08] hours; P = 0.001). Group RK demonstrated significantly lower postoperative pain scores at 6,10, and 16 h postoperatively (P < 0.004) and reduced consumption of rescue analgesia (P < 0.001). The onset of sensory blockade was comparable with a higher incidence of respiratory depression in Group RD (P = 0.02). Group RK showed higher intraoperative heart rate and mean arterial pressure, though values remained within clinically acceptable limits. Ketamine (0.5 mg/kg) as an adjuvant to ropivacaine for SNB in awake craniotomy provides longer postoperative analgesia and reduced rescue analgesic requirements compared with dexmedetomidine, with a lower incidence of respiratory depression. Dexmedetomidine offers superior hemodynamic attenuation to noxious stimuli. Larger multicenter studies are warranted to establish optimal adjuvant selection. Clinical Trials Registry-India (CTRI): CTRI/2024/01/061259, https://ctri.nic.in/Clinicaltrials/pmaindet2.php?EncHid=OTY2NDQ=&Enc=&userName= Date of registration: 09/01/2024 Date of enrolment of first patient: 15/01/2024 Principal Investigator: Dr Ankur Luthra.
- 17 November 2025
- Published by Wolters Kluwer Health in Journal of Neurosurgical Anesthesiology
- Vol. 38 (3) , 202-210
Comparison of the Effect of Low-dose and Standard-dose Dexmedetomidine Infusion on Neurological Outcomes in Patients With Aneurysmal Subarachnoid Hemorrhage Undergoing Aneurysmal Neck Clipping: a Randomized Controlled Trial
Background: Recent studies have shown a potential neuroprotective role of dexmedetomidine in subarachnoid hemorrhage. However, its effect on neurological outcomes and optimal dosing regimen remains unclear. Methods: We randomized 75 adults with good grade aneurysmal subarachnoid hemorrhage undergoing clipping to receive dexmedetomidine, low-dose (Group D1,0.2 μg kg −1 h −1 , n = 25), standard dose (Group D2, 0.5 μg kg −1 h −1 , n = 25), or normal saline (Group C, n = 25) commenced postinduction of anesthesia and continued for 24 hours. Our primary objective was to assess rates of good functional outcome, defined as a modified Rankin Scale (mRS) Score of 0 to 2, at hospital discharge. Secondary outcomes included rates of good functional outcome at 3 months, levels of blood lactate, S100β, and Neuron Specific Enolase (NSE), incidence of vasospasm, delayed cerebral ischemia (DCI), and cerebral dysautoregulation. Results: Neurological outcome at discharge was better in Group D1 as compared to Group C (mRS 0 to 2, Group D1 vs. C; 19 (76%) vs. 9 (36%), P = 0.02), while it was similar in Group D2 as compared to D1 and C. Neurological outcome at 3 months was comparable among the 3 groups. The lactate levels were significantly lower in Group D1 as compared to Groups D2 and C at 12 and 24 hours. The levels of NSE and S100β were significantly lower in D1 and D2 as compared to Group C. Other measured parameters were comparable. Conclusion: Low-dose dexmedetomidine was associated with a favourable neurological outcome at discharge compared to the control group. Larger trials are necessary to conclusively establish the neuroprotective effect of dexmedetomidine.
- 17 November 2025
- Published by Wolters Kluwer Health in Journal of Neurosurgical Anesthesiology
- Vol. 38 (3) , 202-210
Comparison of the Effect of Low-dose and Standard-dose Dexmedetomidine Infusion on Neurological Outcomes in Patients With Aneurysmal Subarachnoid Hemorrhage Undergoing Aneurysmal Neck Clipping: a Randomized Controlled Trial
Background: Recent studies have shown a potential neuroprotective role of dexmedetomidine in subarachnoid hemorrhage. However, its effect on neurological outcomes and optimal dosing regimen remains unclear. Methods: We randomized 75 adults with good grade aneurysmal subarachnoid hemorrhage undergoing clipping to receive dexmedetomidine, low-dose (Group D1,0.2 μg kg −1 h −1 , n = 25), standard dose (Group D2, 0.5 μg kg −1 h −1 , n = 25), or normal saline (Group C, n = 25) commenced postinduction of anesthesia and continued for 24 hours. Our primary objective was to assess rates of good functional outcome, defined as a modified Rankin Scale (mRS) Score of 0 to 2, at hospital discharge. Secondary outcomes included rates of good functional outcome at 3 months, levels of blood lactate, S100β, and Neuron Specific Enolase (NSE), incidence of vasospasm, delayed cerebral ischemia (DCI), and cerebral dysautoregulation. Results: Neurological outcome at discharge was better in Group D1 as compared to Group C (mRS 0 to 2, Group D1 vs. C; 19 (76%) vs. 9 (36%), P = 0.02), while it was similar in Group D2 as compared to D1 and C. Neurological outcome at 3 months was comparable among the 3 groups. The lactate levels were significantly lower in Group D1 as compared to Groups D2 and C at 12 and 24 hours. The levels of NSE and S100β were significantly lower in D1 and D2 as compared to Group C. Other measured parameters were comparable. Conclusion: Low-dose dexmedetomidine was associated with a favourable neurological outcome at discharge compared to the control group. Larger trials are necessary to conclusively establish the neuroprotective effect of dexmedetomidine.
- Open Access
- 12 February 2025
- Published by Elsevier in World Neurosurgery
- Vol. 195, 123678
Comparison of Intraoperative Propofol-Dexmedetomidine and Ketofol-Dexmedetomidine Infusions on Recovery from Anesthesia in Patients Undergoing Endoscopic Transsphenoidal Pituitary Surgeries: A Randomized Controlled Trial
- 12 February 2025
- Published by Elsevier in World Neurosurgery
- Vol. 195, 123678
Open AccessComparison of Intraoperative Propofol-Dexmedetomidine and Ketofol-Dexmedetomidine Infusions on Recovery from Anesthesia in Patients Undergoing Endoscopic Transsphenoidal Pituitary Surgeries: A Randomized Controlled Trial
- Open Access
- 1 July 2024
- Published by Evidence Journals in The Evidence
- Vol. 2 (3)
Artificial intelligence and ChatGPT in neuroanesthesia and neurocritical practice: a revolution or a discombobulation
The advent of Artificial Intelligence (AI) and ChatGPT has marked its effect on the various aspects of society and the medical field is not exempt from its influence. The AI and ChatGPT can prove to be of great assistance to neuroanesthesiologists by helping in clinical decision-making during the perioperative period and in the neurocritical management and prognostication of the patients. Along with that, it can also help in medical recordkeeping, translations of medical education and research. However, the progress of technology isn’t exempted from its evil potential. The boon of increasing productivity and lightening the load off Neuroanesthesiologist’ shoulders comes with the bane of false information, misinterpretation, piracy and plagiarism. Hence, AI and ChatGPT should be allowed to analyze or develop sensitive information or decisions only under the scrutiny of a human assessment.
- 1 July 2024
- Published by Evidence Journals in The Evidence
- Vol. 2 (3)
Open AccessArtificial intelligence and ChatGPT in neuroanesthesia and neurocritical practice: a revolution or a discombobulation
The advent of Artificial Intelligence (AI) and ChatGPT has marked its effect on the various aspects of society and the medical field is not exempt from its influence. The AI and ChatGPT can prove to be of great assistance to neuroanesthesiologists by helping in clinical decision-making during the perioperative period and in the neurocritical management and prognostication of the patients. Along with that, it can also help in medical recordkeeping, translations of medical education and research. However, the progress of technology isn’t exempted from its evil potential. The boon of increasing productivity and lightening the load off Neuroanesthesiologist’ shoulders comes with the bane of false information, misinterpretation, piracy and plagiarism. Hence, AI and ChatGPT should be allowed to analyze or develop sensitive information or decisions only under the scrutiny of a human assessment.
- 5 February 2024
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 74 (1) , 1-7
The Role of Serum Matrix Metalloproteinase-9 as a Predictor of Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage
Delayed cerebral ischemia (DCI) is one of the major causes of a poor neurological outcome following aneurysmal subarachnoid hemorrhage (aSAH). Several biomarkers, including matrix metalloproteinase-9 (MMP-9), have been evaluated to predict the development of DCI for timely management. This prospective cohort study was done on 98 patients with aSAH presenting within 72 h of the ictus. Serum samples were collected preoperatively, 7 days after ictus, 10 days after ictus, or when the patient developed DCI, whichever was earlier. The primary objective was to correlate the serum MMP-9 levels with the development of DCI. The secondary objectives were to correlate the serum MMP-9 levels with sonographic vasospasm and the neurological outcome. There was no correlation between the serum MMP-9 levels and the development of DCI (p = 0.37). Similarly, there was no correlation between the serum MMP-9 levels and the sonographic vasospasm (0.05) nor with the modified Rankin Scale (mRS) at discharge (p = 0.27), mRS at 3 months (p = 0.22), and Glasgow Outcome Scale Extended (GOSE) at 3 months (p = 0.15). Serum MMP-9 levels do not predict the development of DCI following aSAH.
- 5 February 2024
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 74 (1) , 1-7
The Role of Serum Matrix Metalloproteinase-9 as a Predictor of Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage
Delayed cerebral ischemia (DCI) is one of the major causes of a poor neurological outcome following aneurysmal subarachnoid hemorrhage (aSAH). Several biomarkers, including matrix metalloproteinase-9 (MMP-9), have been evaluated to predict the development of DCI for timely management. This prospective cohort study was done on 98 patients with aSAH presenting within 72 h of the ictus. Serum samples were collected preoperatively, 7 days after ictus, 10 days after ictus, or when the patient developed DCI, whichever was earlier. The primary objective was to correlate the serum MMP-9 levels with the development of DCI. The secondary objectives were to correlate the serum MMP-9 levels with sonographic vasospasm and the neurological outcome. There was no correlation between the serum MMP-9 levels and the development of DCI (p = 0.37). Similarly, there was no correlation between the serum MMP-9 levels and the sonographic vasospasm (0.05) nor with the modified Rankin Scale (mRS) at discharge (p = 0.27), mRS at 3 months (p = 0.22), and Glasgow Outcome Scale Extended (GOSE) at 3 months (p = 0.15). Serum MMP-9 levels do not predict the development of DCI following aSAH.
- Open Access
- 1 January 2024
- Published by Wolters Kluwer Health in Journal of Pediatric Neurosciences
- Vol. 19 (1) , 22-24
Management of Vein of Galen Aneurysmal Malformation in a Neonate: A Tightrope Walk
The vein of Galen aneurysmal malformation (VGAM) is a rare congenital intracranial high-flow arterio-venous shunt that can cause high-output cardiac failure in the neonate. Embolization of the VGAM by interventional neuroradiology is the procedure of choice. Treatment decisions should be individualized and based on a scoring system like the Bicetre score. We report our experience of the anesthetic management of a neonate with high-output cardiac failure who underwent transarterial embolization. We highlight the risk of acute pulmonary edema during the procedure and stress the importance of strict fluid and hemodynamic management.
- 1 January 2024
- Published by Wolters Kluwer Health in Journal of Pediatric Neurosciences
- Vol. 19 (1) , 22-24
Open AccessManagement of Vein of Galen Aneurysmal Malformation in a Neonate: A Tightrope Walk
The vein of Galen aneurysmal malformation (VGAM) is a rare congenital intracranial high-flow arterio-venous shunt that can cause high-output cardiac failure in the neonate. Embolization of the VGAM by interventional neuroradiology is the procedure of choice. Treatment decisions should be individualized and based on a scoring system like the Bicetre score. We report our experience of the anesthetic management of a neonate with high-output cardiac failure who underwent transarterial embolization. We highlight the risk of acute pulmonary edema during the procedure and stress the importance of strict fluid and hemodynamic management.
- 14 December 2023
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 41 (4) , 288-295
Comparison of the efficacy of intranasal atomised dexmedetomidine versus intranasal atomised ketamine as a premedication for sedation and anxiolysis in children undergoing spinal dysraphism surgery
BACKGROUND: Preoperative anxiety leads to adverse clinical outcomes and long-term maladaptive behavioural changes. The role of intranasal atomised dexmedetomidine and atomised ketamine as premedication to produce sedation and anxiolysis in paediatric neurosurgical patients has not been extensively studied. OBJECTIVE: To study the efficacy of intranasal atomised dexmedetomidine and intranasal atomised ketamine as premedication in producing sedation and facilitating smooth induction in children undergoing spinal dysraphism surgery. DESIGN: A prospective randomised double-blind trial. SETTING: A tertiary teaching hospital. PATIENTS: Sixty-four children aged 1 to 10 years undergoing spinal dysraphism surgery METHODS: Children were randomised to receive intranasal atomised dexmedetomidine 2.5 μg kg−1 (Group D, n = 32) and intranasal atomised ketamine 5 mg kg−1 (Group K, n = 32) 30 min before surgery. OUTCOMES MEASURED: The primary outcome was to compare the level of sedation in both groups using the University of Michigan Sedation Score (UMSS). The secondary outcomes included an assessment of the ease of parental separation, intravenous cannulation and satisfactory mask acceptance along with perioperative vitals (heart rate, blood pressure and oxygen saturation). The incidence of emergence agitation and time to discharge were also noted. RESULTS: The degree of sedation was significantly better in Group D as compared to Group K at 20 min (UMSS, 1.55 ± 0.51 versus 1.13 ± 0.34, difference, −0.406; 95% CI, −0.621 to −0.191; P = 0.0001) and 30 min (2.32 ± 0.6 versus 1.94 ± 0.50, difference, −0.374; 95% CI, −0.650 to −0.100; P = 0.007). The ease of parental separation, venous cannulation and mask acceptance (P = 0.83, 0.418 and 0.100 respectively) were comparable in both groups. The heart rate was lower in group D at 10, 20 and 30 min post-drug administration but was clinically insignificant. The incidence of emergence agitation and time to discharge was also similar with no adverse events reported. CONCLUSION: Intranasal atomised dexmedetomidine produces greater sedation as compared to intranasal atomised ketamine with comparable ease of parental separation, venous cannulation and mask acceptance with no adverse effects.
- 14 December 2023
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 41 (4) , 288-295
Comparison of the efficacy of intranasal atomised dexmedetomidine versus intranasal atomised ketamine as a premedication for sedation and anxiolysis in children undergoing spinal dysraphism surgery
BACKGROUND: Preoperative anxiety leads to adverse clinical outcomes and long-term maladaptive behavioural changes. The role of intranasal atomised dexmedetomidine and atomised ketamine as premedication to produce sedation and anxiolysis in paediatric neurosurgical patients has not been extensively studied. OBJECTIVE: To study the efficacy of intranasal atomised dexmedetomidine and intranasal atomised ketamine as premedication in producing sedation and facilitating smooth induction in children undergoing spinal dysraphism surgery. DESIGN: A prospective randomised double-blind trial. SETTING: A tertiary teaching hospital. PATIENTS: Sixty-four children aged 1 to 10 years undergoing spinal dysraphism surgery METHODS: Children were randomised to receive intranasal atomised dexmedetomidine 2.5 μg kg−1 (Group D, n = 32) and intranasal atomised ketamine 5 mg kg−1 (Group K, n = 32) 30 min before surgery. OUTCOMES MEASURED: The primary outcome was to compare the level of sedation in both groups using the University of Michigan Sedation Score (UMSS). The secondary outcomes included an assessment of the ease of parental separation, intravenous cannulation and satisfactory mask acceptance along with perioperative vitals (heart rate, blood pressure and oxygen saturation). The incidence of emergence agitation and time to discharge were also noted. RESULTS: The degree of sedation was significantly better in Group D as compared to Group K at 20 min (UMSS, 1.55 ± 0.51 versus 1.13 ± 0.34, difference, −0.406; 95% CI, −0.621 to −0.191; P = 0.0001) and 30 min (2.32 ± 0.6 versus 1.94 ± 0.50, difference, −0.374; 95% CI, −0.650 to −0.100; P = 0.007). The ease of parental separation, venous cannulation and mask acceptance (P = 0.83, 0.418 and 0.100 respectively) were comparable in both groups. The heart rate was lower in group D at 10, 20 and 30 min post-drug administration but was clinically insignificant. The incidence of emergence agitation and time to discharge was also similar with no adverse events reported. CONCLUSION: Intranasal atomised dexmedetomidine produces greater sedation as compared to intranasal atomised ketamine with comparable ease of parental separation, venous cannulation and mask acceptance with no adverse effects.
- Open Access
- 31 October 2023
- Published by Asian Spine Journal (ASJ) in Asian Spine Journal
- Vol. 17 (5) , 894-903
Comparison of Intraoperative Low-Dose Ketodex and Fentanyl Infusion for Postoperative Analgesia In Spine Surgery: A Prospective Randomized Double-Blind Study
Study Design: Prospective randomized double-blind study.Purpose: To assess the analgesic effects of the combination of a low-dose ketamine and dexmedetomidine (ketodex) infusion and compare it with that of fentanyl for postoperative analgesia after spine surgeries.Overview of Literature: Adequate pain management following spine surgeries is crucial. Approximately 57% of patients experience inadequate pain control in the first 24 hours following elective spine surgery, which is attributable to the extensive soft tissue and muscle damage.Methods: The study included 60 patients graded American Society of Anesthesiologists I and II and scheduled for thoracolumbar spine surgery involving >3 vertebral levels. The patients were divided into two groups: group KD (ketodex) and group F (fentanyl). The primary objective was to compare the postoperative analgesic requirements among the groups. The secondary objectives included a comparison of the intraoperative anesthetic requirements, postoperative pain scores, hemodynamic parameters, side effects of the study drugs, and the duration of post-anesthesia care unit stay of both the groups.Results: Ketodex use prolonged the mean time to first rescue analgesia (22.00±2.30 hours vs. 11.69±3.02 hours, p 0.05). The postoperative pain scores were significantly lower in the group KD than in group F at most timepoints (p <0.05). Patients in group KD had a shorter post-anesthesia care unit stay than group F did (p 3 vertebral levels to achieve prolonged analgesia without any opioidrelated side effects.
- 31 October 2023
- Published by Asian Spine Journal (ASJ) in Asian Spine Journal
- Vol. 17 (5) , 894-903
Open AccessComparison of Intraoperative Low-Dose Ketodex and Fentanyl Infusion for Postoperative Analgesia In Spine Surgery: A Prospective Randomized Double-Blind Study
Study Design: Prospective randomized double-blind study.Purpose: To assess the analgesic effects of the combination of a low-dose ketamine and dexmedetomidine (ketodex) infusion and compare it with that of fentanyl for postoperative analgesia after spine surgeries.Overview of Literature: Adequate pain management following spine surgeries is crucial. Approximately 57% of patients experience inadequate pain control in the first 24 hours following elective spine surgery, which is attributable to the extensive soft tissue and muscle damage.Methods: The study included 60 patients graded American Society of Anesthesiologists I and II and scheduled for thoracolumbar spine surgery involving >3 vertebral levels. The patients were divided into two groups: group KD (ketodex) and group F (fentanyl). The primary objective was to compare the postoperative analgesic requirements among the groups. The secondary objectives included a comparison of the intraoperative anesthetic requirements, postoperative pain scores, hemodynamic parameters, side effects of the study drugs, and the duration of post-anesthesia care unit stay of both the groups.Results: Ketodex use prolonged the mean time to first rescue analgesia (22.00±2.30 hours vs. 11.69±3.02 hours, p 0.05). The postoperative pain scores were significantly lower in the group KD than in group F at most timepoints (p <0.05). Patients in group KD had a shorter post-anesthesia care unit stay than group F did (p 3 vertebral levels to achieve prolonged analgesia without any opioidrelated side effects.